Rare LMNA–NTRK1 and GOPC–ROS1 fusions have been previously reported in glioblastoma [19,20], and their incidence in the Combined cohort is very low, at 0.5% and 1.1%, respectively (Figure 3a). Here, ROS1 is linked to glioblastoma.